Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Kymera Therapeutics (KYMR) Preferred Shares Issued (2019 - 2020)

Historic Preferred Shares Issued for Kymera Therapeutics (KYMR) over the last 2 years, with Q2 2020 value amounting to -$19000.0.

  • Kymera Therapeutics' Preferred Shares Issued changed N/A to -$19000.0 in Q2 2020 from the same period last year, while for Dec 2020 it was $88.2 million, marking a year-over-year change of. This contributed to the annual value of $88.2 million for FY2020, which is 31628.19% up from last year.
  • According to the latest figures from Q2 2020, Kymera Therapeutics' Preferred Shares Issued is -$19000.0.
  • Kymera Therapeutics' Preferred Shares Issued's 5-year high stood at $88.2 million during Q1 2020, with a 5-year trough of -$19000.0 in Q2 2020.